PharmaCyte Biotech Closer to Submitting IND with Successful Completion of Clinical Trial Product

NEXT STORY
Family Wellness Center of Norman Hosts Open House to Introduce Newly Offered FDA-Cleared Deep TMS Helmet to Treat Major Depressive Disorder (MDD)
PREV STORY
Syapse Appoints Dr. Thomas D. Brown as Chief Medical Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Inovio HIV Vaccine, Which Generated Near 100% Immune Responses, Sustained Durable Memory Responses Measured One Year After The Start of Clinical Trial

PENNVAX®-GP generated among highest levels of immune responses ever demonstrated in a human HIV ...

author_avatar
NASDAQ Market News

Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia

author_avatar
NASDAQ Market News

Global Point-of-Care Diagnostics, Health & Biosensors Conference 2019: POC Testing Landscape, Novel Technologies to Regulatory Approval (San Diego, CA, United States – October 7-9, 2019)

author_avatar
NASDAQ Market News